ORAL TRANSMUCOSAL DELIVERY: AN IN-DEPTH REVIEW OF BUCCAL PATCH FABRICATION, INNOVATIONS AND APPLICATIONS
DOI:
https://doi.org/10.22159/ijap.2026v18i1.56224Keywords:
Mucoadhesive, Buccal mucosa, Drug delivery, Penetration enhancers, PatentsAbstract
Mucoadhesive buccal patches have attracted considerable interest over the last decade because of their potential as a novel drug delivery system (NDDS) for several therapeutic uses. Mucoadhesive buccal patches stick to the buccal mucosa, ensuring controlled and prolonged release of drugs, thereby largely avoiding first-pass metabolism and enhancing drug bioavailability. The present paper summarizes a thorough collection of mucoadhesive buccal patches with special emphasis on design, formulation, processing, and application in drug delivery. In addition, this article emphasizes new patent research dealing with mucoadhesive buccal patches. It provides an overview of the existing patents and discusses their novelty, usefulness, and potentiality for commercialization. The all-encompassing analysis contained within this article serves to provide as an informative tool for researchers, pharmaceutical scientists, and entrepreneurs interested in the development of mucoadhesive buccal patches as a potential drug delivery system. It also stimulates future research and innovation in this field, with potential for future advancement.
References
1. Hearnden V, Sankar V, Hull K, Juras DV, Greenberg M, Kerr AR, et al. New developments and opportunities in oral mucosal drug delivery for local and systemic disease. Adv Drug Deliv Rev. 2012;64(1):16-28.
2. Adhikari SN, Nayak BS, Nayak AK, Mohanty B. Formulation and evaluation of buccal patches for delivery of atenolol. AAPS PharmSciTech. 2010;11(3):1038-1044.
3. Heemstra LB, Finnin BC, Nicolazzo JA. The buccal mucosa as an alternative route for the systemic delivery of risperidone. J Pharm Sci. 2010;99(11):4584-4592.
4. Parmar HG, Jain JJ, Patel TK, Patel VM. Buccal patch: A technical note. Int J Pharm Sci Rev Res. 2010;4(3):178-182.
5. Rohani Shirvan A, Hemmatinejad N, Bahrami SH, Bashari A. Fabrication of multifunctional mucoadhesive buccal patch for drug delivery applications. J Biomed Mater Res A. 2021;109(12):2640-2656.
6. Jacob S, Nair AB, Boddu SH, Gorain B, Sreeharsha N, Shah J. An updated overview of the emerging role of patch and film-based buccal delivery systems. Pharmaceutics. 2021;13(8):1206.
7. Sabra R, Kirby D, Chouk V, Malgorzata K, Mohammed AR. Buccal absorption of biopharmaceutics classification system III drugs: formulation approaches and mechanistic insights. Pharmaceutics. 2024;16(12):1563.
8. Korbonits M, Slawik M, Cullen D, Ross RJ, Stalla G, Schneider H, et al. A comparison of a novel testosterone bioadhesive buccal system, Striant, with a testosterone adhesive patch in hypogonadal males. J Clin Endocrinol Metab. 2004;89(5):2039-2043.
9. Merkle HP, Anders R, Wermerskirchen A. Mucoadhesive buccal patches for peptide delivery. In: Bioadhesive drug delivery systems. Boca Raton (FL): CRC Press; 2024. p. 105-136.
10. Venkatalakshmi R, Sudhakar Y, Chetty MC, Sasikala C, Varma MM. Buccal drug delivery using adhesive polymeric patches. Int J Pharm Sci Res. 2012;3(1):35-41.
11. Morales JO, McConville JT. Manufacture and characterization of mucoadhesive buccal films. Eur J Pharm Biopharm. 2011;77(2):187-199.
12. Shojaei AH, Berner B, Li X. Transbuccal delivery of acyclovir: I. In vitro determination of routes of buccal transport. Pharm Res. 1998;15:1182-1188.
13. Shaikh R, Singh TR, Garland MJ, Woolfson AD, Donnelly RF. Mucoadhesive drug delivery systems. J Pharm Bioallied Sci. 2011;3(1):89-100.
14. Gandhi PA, Patel M, Patel K, Patel N. A review article on mucoadhesive buccal drug delivery system. Int J Pharm Res Dev. 2011;3(5):159-173.
15. Mujoriya R, Dhamande K, Wankhede U, Angure S. A review on study of buccal drug delivery system. Innov Syst Des Eng. 2011;2(3):200-204.
16. Prajapati V, Bansal M, Sharma PK. Mucoadhesive buccal patches and use of natural polymer in its preparation—a review. Int J PharmTech Res. 2012;4(2):582-589.
17. Salamat-Miller N, Chittchang M, Johnston TP. The use of mucoadhesive polymers in buccal drug delivery. Adv Drug Deliv Rev. 2005;57(11):1666-1691.
18. Khutoryanskiy VV. Advances in mucoadhesion and mucoadhesive polymers. Macromol Biosci. 2011;11(6):748-764.
19. Williams AC, Barry BW. Penetration enhancers. Adv Drug Deliv Rev. 2012;64:128-137.
20. Morales JO, Huang S, Williams III RO, McConville JT. Films loaded with insulin-coated nanoparticles (ICNP) as potential platforms for peptide buccal delivery. Colloids Surf B Biointerfaces. 2014;122:38-45.
21. Gopalakrishnan S, Pandey N, Tamiz AP, Vere J, Carrasco R, Somerville R, et al. Mechanism of action of ZOT-derived peptide AT-1002, a tight junction regulator and absorption enhancer. Int J Pharm. 2009;365(1-2):121-130.
22. Lu Y, Ma Y, Wu W. Ionic liquids: Emerging chemical permeation enhancers. Medcomm Biomater Appl. 2024;3(2):e81.
23. Aungst BJ. Absorption enhancers: applications and advances. AAPS J. 2012;14(1):10-18.
24. Iyer H, Khedkar A, Verma M. Oral insulin–a review of current status. Diabetes Obes Metab. 2010;12(3):179-185.
25. Ramadon D, McCrudden MT, Courtenay AJ, Donnelly RF. Enhancement strategies for transdermal drug delivery systems: Current trends and applications. Drug Deliv Transl Res. 2022;12:758-791.
26. Park K, Kwon IC, Park K. Oral protein delivery: Current status and future prospect. ReactFunctPolym. 2011;71(3):280-287.
27. Nicolazzo JA, Reed BL, Finnin BC. Buccal penetration enhancers—how do they really work? J Control Release. 2005;105(1-2):1-15.
28. Som I, Bhatia K, Yasir M. Status of surfactants as penetration enhancers in transdermal drug delivery. J Pharm Bioallied Sci. 2012;4(1):2-9.
29. Hassan N, Ahad A, Ali M, Ali J. Chemical permeation enhancers for transbuccal drug delivery. Expert Opin Drug Deliv. 2010;7(1):97-112.
30. Palem CR, Kumar Battu S, Gannu R, Yamsani VV, Repka MA, Yamsani MR. Role of cyclodextrin complexation in felodipine-sustained release matrix tablets intended for oral transmucosal delivery: In vitro and ex vivo characterization. Pharm Dev Technol. 2012;17(3):321-332.
31. Şenel S, Kremer M, Kaş S, Wertz PW, Hıncal AA, Squier CA. Enhancing effect of chitosan on peptide drug delivery across buccal mucosa. Biomaterials. 2000;21(20):2067-2071.
32. Padula C, Pescina S, Nicoli S, Santi P. New insights on the mechanism of fatty acids as buccal permeation enhancers. Pharmaceutics. 2018;10(4):201.
33. Jampilek J, Brychtova K. Azone analogues: Classification, design, and transdermal penetration principles. Med Res Rev. 2012;32(5):907-947.
34. Sood A, Panchagnula R. Peroral route: an opportunity for protein and peptide drug delivery. Chem Rev. 2001;101(11):3275-3304.
35. Hou SY, Flynn GL. Influences of 1-dodecylazacycloheptan-2-one on permeation of membranes by weak electrolytes. 1. Theoretical analysis of weak electrolyte diffusion through membranes and studies involving silicone rubber membranes. J Pharm Sci. 1997;86(1):85-91.
36. Cox DS, Gao H, Raje S, Scott KR, Eddington ND. Enhancing the permeation of marker compounds and enaminone anticonvulsants across Caco-2 monolayers by modulating tight junctions using zonula occludens toxin. Eur J Pharm Biopharm. 2001;52(2):145-150.
37. Khanna R, Agarwal SP, Ahuja A. Preparation and evaluation of muco-adhesive buccal films of clotrimazole for oral Candida infections. Indian J Pharm Sci. 1997;59(6):299-305.
38. Lodhi M, Dubey A, Narayan R, Prabhu P, Priya S. Formulation and evaluation of buccal film of Ivabradine hydrochloride for the treatment of stable angina pectoris. Int J Pharm Investig. 2013;3(1):47-53.
39. Perumal V, Lutchman D, Mackraj I, Govender T. Formulation of monolayered films with drug and polymers of opposing solubilities. Int J Pharm. 2008;358(1-2):184-191.
40. Huanbutta K, Burapapadh K, Sriamornsak P, Sangnim T. Practical application of 3D printing for pharmaceuticals in hospitals and pharmacies. Pharmaceutics. 2023;15(7):1877.
41. Huanbutta K, Sriamornsak P, Singh I, Sangnim T. Manufacture of 2D-printed precision drug-loaded orodispersible film prepared from tamarind seed gum substrate. Appl Sci. 2021;11(13):5852.
42. Nafee NA, Ismail FA, Boraie NA, Mortada LM. Mucoadhesive buccal patches of miconazole nitrate: in vitro/in vivo performance and effect of ageing. Int J Pharm. 2003;264(1-2):1-14.
43. Elkanayati RM, Chambliss WG, Omari S, Almutairi M, Repka MA, Ashour EA. Mucoadhesive buccal films for treatment of xerostomia prepared by coupling HME and 3D printing technologies. J Drug Deliv Sci Technol. 2022;75:103660.
44. Oh B-C, Jin G, Park C, Park JB, Lee BJ. Preparation and evaluation of identifiable quick response (QR)-coded orodispersible films using 3D printer with directly feeding nozzle. Int J Pharm. 2020;584:119405.
45. Montenegro-Nicolini M, Reyes PE, Jara MO, Vuddanda PR, Neira-Carrillo A, Butto N, et al. The effect of inkjet printing over polymeric films as potential buccal biologics delivery systems. AAPS PharmSciTech. 2018;19(8):3376-3387.
46. Carou-Senra P, Awad A, Basit AW, Alvarez-Lorenzo C, Goyanes A. Harnessing handheld inkjet printing technology for rapid and decentralised fabrication of drug-loaded hydroxypropyl cellulose buccal films. CarbohydrPolym Technol Appl. 2025;9:100724.
47. Huanbutta K, Sittikijyothin W, Sangnim T. Development and characterization of bilayer wound healing patch nanofiber fabricated by electrospinning. J Nano Res. 2019;59:46-56.
48. Sangnim T, Limmatvapirat S, Nunthanid J, Sriamornsak P, Sittikijyothin W, Wannachaiyasit S, et al. Design and characterization of clindamycin-loaded nanofiber patches composed of polyvinyl alcohol and tamarind seed gum and fabricated by electrohydrodynamic atomization. Asian J Pharm Sci. 2018;13(5):450-458.
49. Huanbutta K, Sangnim T, Limmatvapirat S, Nunthanid J, Sriamornsak P. Design and characterization of prednisolone-loaded nanoparticles fabricated by electrohydrodynamic atomization technique. Chem Eng Res Des. 2016;109:816-823.
50. Teo WE, Ramakrishna S. A review on electrospinning design and nanofibre assemblies. Nanotechnology. 2006;17(14):R89-R106.
51. Nguyen DN, Clasen C, Van den Mooter G. Pharmaceutical applications of electrospraying. J Pharm Sci. 2016;105(9):2601-2620.
52. Sudhakar Y, Kuotsu K, Bandyopadhyay A. Buccal bioadhesive drug delivery—a promising option for orally less efficient drugs. J Control Release. 2006;114(1):15-40.
53. Seema, Kumar K, Teotia D. A comprehensive review on buccal patches. GSC Biol Pharm Sci. 2020;13:130-135.
54. Zaman M, Chaurasiya V. Polymers used in buccal film: A review. Des Monomers Polym. 2015;18:105-111.
55. Gittings S, Turnbull N, Henry B, Roberts CJ, Gershkovich P. Characterisation of human saliva as a platform for oral dissolution medium development. Eur J Pharm Biopharm. 2015;91:16-24.
56. Khan J, Williams R, Frith WJ, Menzies AR, Ang S, Chen S, et al. Probing the interactions of chitosan-based nanoparticles with mucin and their implications for oral drug delivery. Int J Pharm. 2017;532(1):521-530.
57. Klimek J, Hellwig E, Ahrens G. Artificial saliva formulations for in vitro studies on dental hard tissue demineralization: influence of composition and stability. Caries Res. 2020;54(2):123-131.
58. Marques MR, Loebenberg R, Almukainzi M. Simulated biological fluids with possible application in dissolution testing. Dissolution Technol. 2011;18(3):15-28.
59. International Organization for Standardization. Dentistry — Corrosion test methods for metallic materials. ISO 10271:2020. Geneva (CH): ISO; 2020.
60. Huanbutta K, Terada K, Sriamornsak P, Nunthanid J. Advanced technologies for assessment of polymer swelling and erosion behaviors in pharmaceutical aspect. Eur J Pharm Biopharm. 2013;83(3):315-321.
61. Siddiqui M, Garg G, Sharma PK. A short review on a novel approach in oral fast dissolving drug delivery system and their patents. Adv Biol Res. 2011;5(6):291-303.
62. Sangnim T, Sriamornsak P, Theerawatcharothai S, Fugnoot K, Wattanathammanon P, Vongsak B, et al. Development of fast dissolving orodispersible films loaded with cannabis extract. Sci Eng Health Stud. 2022;16:e22050023.
63. Hiremath J, Sarfaraz M, Hiremath D, Sarudkar S. Preparation and physicochemical characterization of simvastatin loaded mucoadhesive bilayered tablet. Indian J Nov Drug Deliv. 2009;1(1):18-24.
64. United States Pharmacopeial Convention. <1151> Pharmaceutical dosage forms. In: United States Pharmacopeia and National Formulary (USP 47-NF 42). Rockville (MD): United States Pharmacopeial Convention; 2024.
65. Anil A, Sudheer P. Design and evaluation of mucoadhesive buccal patch of ramipril. Int J Pharm Sci Rev Res. 2018;50(2):121-129.
66. Deshmane SV, Channawar MA, Chandewar AV, Joshi UM, Biyani KR. Chitosan based sustained release mucoadhesive buccal patches containing verapamil HCL. Int J Pharm Pharm Sci. 2009;1(1):216-229.
67. El-Kamel AH, Ashri LY, Alsarra IA. Micromatricial metronidazole benzoate film as a local mucoadhesive delivery system for treatment of periodontal diseases. AAPS PharmSciTech. 2007;8(3):E75.
68. Kumar A, Phatarpekar V, Pathak N, Padhee K, Garg M, Sharma N. Formulation development and evaluation of carvedilol bioerodable buccal mucoadhesive patches. Int J Compr Pharm. 2011;3(7):1-5.
69. Boyes RN, Perkins B, Strobel JN, Dunn RL, inventors; Noven Pharmaceuticals Inc, assignee. Buccal local anaesthetic. World patent WO 1989010740. 1989 Nov 16
70. Flockhart IR, Cort JH, inventors; Cort Jitka East Riding Laboratories Ltd, assignee. Desmopressin buccal patch composition. United States patent US 5298256A. 1994 Apr 29.
71. Kurkela K, Marvola M, Larma I, Virtanen R, Karlsson M, inventors; Orion Corporation, assignee. Transmucosal formulations of levosimendan. United States patent US 6399610B1. 2002 Apr 4.
72. Repka MA, Repka SL, McGinity JW, inventors; Board of Regents, The University of Texas System, assignee. Bioadhesive hot-melt extruded film for topical and mucosal adhesion applications and drug delivery and process for preparation thereof. United States patent US 6375963B1. 2002 Apr 23.
73. Haley J, inventor. Soft, adherent, soluble oral patch. United States patent application US 20030124178A1. 2003 Jul 3.
74. Zerbe HG, Guo JH, Serino A, inventors; LTS Lohmann Therapie-Systeme AG, assignee. Water soluble film for oral administration with instant wettability. United States patent US 6709671B2. 2004 Mar 23.
75. Rademacher T, Falkenhausen CV, inventors; LTS Lohmann Therapie Systeme AG, assignee. Transmucosal form of administration with reduced mucosal irritation. World patent WO 2005000263A1. 2005 Jan 6.
76. Durschlag ME, Kehoe GS, inventors. Edible film for transmucosal delivery of nutritional supplements. World patent WO 006119286A1. 2006 Nov 9.
77. Fuisz RC, inventor. Aquestive Therapeutics Inc, assignee. Film bandage for mucosal administration of actives. World patent WO 2007084617A2. 2007 Jul 27.
78. Haber M, Kristmundsdottir T, Skulason S, inventors; Biota Ltd, assignee. Orally administrable films and preparation thereof. World patent WO 2007125533A2. 2007 Nov 8.
79. Biegajski JE, inventor; Dow Pharmaceutical Sciences Inc, assignee. Two-phase mucoadhesive composition. World patent WO 2008002353A1. 2008 Jan 3.
80. Malcovati L, inventor. Canker sore patch. World patent WO 2010006612A3. 2010 Jan 21.
81. Daud AS, Sapkal NP, Bonde MN, inventors. Water soluble pharmaceutical film with enhanced stability. World patent WO 2015083181A2. 2015 Jun 11.
82. McConville JT, Morales JO, Ross A, inventors; UNM Rainforest Innovations, assignee. Bioadhesive films for local and/or systemic delivery. United States patent application US 20160128947A1. 2016 May 12.
83. Kovarik JE, inventor; Seed Health Inc, assignee. Buccal bioadhesive strip and method of treating snoring and sleep apnea. United States patent application US 9549842B2. 2017 Jan 24.
84. Myers GL, Hilbert SD, Boone BJ, Bogue BA, Sanghvi P, Hariharan M, inventors; Indivior UK Ltd, assignee. Sublingual and buccal film compositions. United States patent application US 9687454B2. 2017 Jun 27.
85. Scaife MC, inventor. Sublingual or buccal administration of dim for treatment of skin diseases. World patent WO 2018051183. 2018 Mar 22.
86. Mavely L, Sonaje K, Indu AG, inventors; Axio Biosolutions Pvt Ltd, assignee. Mucoadhesive preparations, methods and applications thereof. World patent WO 2018083643A1. 2018 May 11.
87. Bogdahn M, et al., inventors; Esocap AG, assignee. Pharmaceutical dosage form for application to mucous membranes. United States patent application US 20180036251A1. 2018 Feb 8.
88. Werle M, Föger F, inventors; Cyprumed GmbH, assignee. Pharmaceutical compositions for the transmucosal delivery of therapeutic peptides and proteins. World patent WO 2019193204A1. 2019 Oct 10.
89. Yang RK, Fuisz RC, Myers GL, Fuisz JM, inventors; Aquestive Therapeutics Inc, assignee. Thin film with non-self-aggregating uniform heterogeneity and drug delivery systems made therefrom. United States patent application US 20200163901A1. 2020 May 28.
90. Mallery SR, Larsen PE, Stoner GD, Schwendeman SP, Desai KG, inventors; Ohio State University, assignee. Controlled release mucoadhesive systems. United States patent application US 10758619B2. 2020 Sep 1.
91. Tarate VS, Chougule PN, Chougule NB, Shinde VR, Shelke SS, Kulkarni AS, et al., inventors. Multilayered buccal patch of antihypertensive drugs. South Africa patent ZA 202213524B. 2023 May 31.
92. Toong HD, Altmann WC, inventors; Neurostim Technologies LLC, assignee. Detection and treatment of obstructive sleep apnea. United States patent application US 20230083643A1. 2023 Mar 16.
93. Badawi P, inventor; Sight Sciences Inc., assignee. Dry eye treatment systems. United States patent application US 20250228702A1. 2025 Jul 17.
94. Badawi D, Badawi P, Harshman S, O'Keeffe D, inventors; Sight Sciences Inc., assignee. Controller for dry eye treatment systems. United States patent application US 12257181B2. 2025 Mar 25.
95. Food and Drug Administration (U.S.). Combination products. 21 C.F.R. Part 3. Washington (DC): U.S. Government Publishing Office; 2020.
96. Leoty-Okombi S, Gillaizeau F, Leuillet S, Douillard B, Le Fresne-Languille S, Carton T, et al. Effect of sodium lauryl sulfate (SLS) applied as a patch on human skin physiology and its microbiota. Cosmetics. 2021;8(1):6.
97. Moghimipour E, Ameri A, Handali S. Absorption-enhancing effects of bile salts. Molecules. 2015;20(8):14451-14473.
98. Pat Y, Ogulur I, Yazici D, Mitamura Y, Cevhertas L, Küçükkase OC, et al. Effect of altered human exposome on the skin and mucosal epithelial barrier integrity. Tissue Barriers. 2023;11(4):2133877.
99. Maher S, Geoghegan C, Brayden DJ. Safety of surfactant excipients in oral drug formulations. Adv Drug Deliv Rev. 2023;202:115086.
100. Reuther M, Rollet N, Debeaufort F, Chambin O. Orodispersible films prepared by hot-melt extrusion versus solvent casting. Int J Pharm. 2025;675:125536.
101. Juarez-Navarro KJ, Guarino V, Alvarez-Perez MA. Converging electrospinning and 3D-printing technologies: From innovative design for tissue engineering to global patent trends and technology transfer. Fibers. 2025;13(6):83.
102. Carou‐Senra P, Rodríguez‐Pombo L, Awad A, Basit AW, Alvarez‐Lorenzo C, Goyanes A. Inkjet printing of pharmaceuticals. Adv Mater. 2024;36(11):2309164.
103. Mersanne A, Foresti R, Martini C, Caffarra Malvezzi C, Rossi G, Fornasari A, et al. In-house fabrication and validation of 3D-printed custom-made medical devices for planning and simulation of peripheral endovascular therapies. Diagnostics. 2024;15(1):8.
Published
How to Cite
Issue
Section
Copyright (c) 2025 KAMPANART HUANBUTTA, TANUJ KUMAR, SANDEEP KUMAR, VANDANA KHARB, TANIKAN SANGNIM, KITTIPAT SUWANPITAK, INDERBIR SINGH
This work is licensed under a Creative Commons Attribution 4.0 International License.
